The use of trimeric isoleucine-zipper fusion proteins to study surface-receptor-ligand interactions in natural killer cells

Journal of Immunological Methods

Volumn 296, Issue 1-2, 2005, Pages 149-158

  Stark, Sebastian ^a   Flaig, Ruediger M ^a   Sandusky, Mina ^a   Watzl, Carsten ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Natural killer cells; Receptor ligand interactions; Recombinant fusion proteins

Indexed keywords

FC RECEPTOR; HYBRID PROTEIN; IMMUNOGLOBULIN; ISOLEUCINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; LIGAND BINDING; MOLECULAR INTERACTION; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RECEPTOR BINDING;

AMINO ACID MOTIFS; CYTOTOXICITY TESTS, IMMUNOLOGIC; CYTOTOXICITY, IMMUNOLOGIC; HUMANS; ISOLEUCINE; KILLER CELLS, NATURAL; LIGANDS; RECEPTORS, IGG; RECEPTORS, IMMUNOLOGIC; RECOMBINANT FUSION PROTEINS;

EID: 12944303651     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jim.2004.11.010     Document Type: Article

References (26)

1. J.D. Altman, P.A. Moss, P.J. Goulder, D.H. Barouch, M.G. McHeyzer-Williams, J.I. Bell, A.J. McMichael, and M.M. Davis Phenotypic analysis of antigen-specific T lymphocytes Science 274 1996 94
2. L. Bacon, R.A. Eagle, M. Meyer, N. Easom, N.T. Young, and J. Trowsdale Two human ULBP/RAET1 molecules with transmembrane regions are ligands for NKG2D J. Immunol. 173 2004 1078
3. R. Biassoni, C. Cantoni, D. Pende, S. Sivori, S. Parolini, M. Vitale, C. Bottino, and A. Moretta Human natural killer cell receptors and co-receptors Immunol. Rev. 181 2001 203
4. D.D. Billadeau, and P.J. Leibson ITAMs versus ITIMs: striking a balance during cell regulation J. Clin. Invest. 109 2002 161
5. C. Bottino, R. Castriconi, D. Pende, P. Rivera, M. Nanni, B. Carnemolla, C. Cantoni, J. Grassi, S. Marcenaro, N. Reymond, M. Vitale, L. Moretta, M. Lopez, and A. Moretta Identification of PVR (CD155) and Nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule J. Exp. Med. 198 2003 557
6. M.H. Brown, K. Boles, P.A. van der Merwe, V. Kumar, P.A. Mathew, and A.N. Barclay 2B4, the natural killer and T cell immunoglobulin superfamily surface protein, is a ligand for CD48 J. Exp. Med. 188 1998 2083
7. M. Falco, E. Marcenaro, E. Romeo, F. Bellora, D. Marras, F. Vely, G. Ferracci, L. Moretta, A. Moretta, and C. Bottino Homophilic interaction of NTBA, a member of the CD2 molecular family: induction of cytotoxicity and cytokine release in human NK cells Eur. J. Immunol. 34 2004 1663
8. R.M. Flaig, S. Stark, and C. Watzl Cutting edge: NTB-A activates NK cells via homophilic interaction J. Immunol. 172 2004 6524
9. A. Fuchs, M. Cella, E. Giurisato, A.S. Shaw, and M. Colonna Cutting edge: CD96 (tactile) promotes NK cell-target cell adhesion by interacting with the poliovirus receptor (CD155) J. Immunol. 172 2004 3994
10. P.B. Harbury, T. Zhang, P.S. Kim, and T. Alber A switch between two-, three-, and four-stranded coiled coils in GCN4 leucine zipper mutants Science 262 1993 1401
11. P.B. Harbury, P.S. Kim, and T. Alber Crystal structure of an isoleucine-zipper trimer Nature 371 1994 80
12. N. Jan Chalupny, C.L. Sutherland, W.A. Lawrence, A. Rein-Weston, and D. Cosman ULBP4 is a novel ligand for human NKG2D Biochem. Biophys. Res. Commun. 305 2003 129
13. P.R. Kumaresan, W.C. Lai, S.S. Chuang, M. Bennett, and P.A. Mathew CS1, a novel member of the CD2 family, is homophilic and regulates NK cell function Mol. Immunol. 39 2002 1
14. W.H. Landschulz, P.F. Johnson, and S.L. McKnight The leucine zipper: a hypothetical structure common to a new class of DNA binding proteins Science 240 1988 1759
15. L.L. Lanier Natural killer cell receptor signaling Curr. Opin. Immunol. 15 2003 308
16. Y. Latchman, P.F. McKay, and H. Reiser Identification of the 2B4 molecule as a counter-receptor for CD48 J. Immunol. 161 1998 5809
17. P.J. Leibson The regulation of lymphocyte activation by inhibitory receptors Curr. Opin. Immunol. 16 2004 328
18. E.O. Long, D.F. Barber, D.N. Burshtyn, M. Faure, M. Peterson, S. Rajagopalan, V. Renard, M. Sandusky, C.C. Stebbins, N. Wagtmann, and C. Watzl Inhibition of natural killer cell activation signals by killer cell immunoglobulin-like receptors (CD158) Immunol. Rev. 181 2001 223
19. W.S. Pear, G.P. Nolan, M.L. Scott, and D. Baltimore Production of high-titer helper-free retroviruses by transient transfection Proc. Natl. Acad. Sci. U. S. A. 90 1993 8392
20. D. Pende, S. Parolini, A. Pessino, S. Sivori, R. Augugliaro, L. Morelli, E. Marcenaro, L. Accame, A. Malaspina, R. Biassoni, C. Bottino, L. Moretta, and A. Moretta Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells J. Exp. Med. 190 1999 1505
21. D.H. Raulet Roles of the NKG2D immunoreceptor and its ligands Nat. Rev., Immunol. 3 2003 781
22. S. Tahara-Hanaoka, K. Shibuya, Y. Onoda, H. Zhang, S. Yamazaki, A. Miyamoto, S. Honda, L.L. Lanier, and A. Shibuya Functional characterization of DNAM-1 (CD226) interaction with its ligands PVR (CD155) and nectin-2 (PRR-2/CD112) Int. Immunol. 16 2004 533
23. P.A. Valdez, H. Wang, D. Seshasayee, M. van Lookeren Campagne, A. Gurney, W.P. Lee, and I.S. Grewal NTB-A, a new activating receptor in T cells that regulates autoimmune disease J. Biol. Chem. 279 2004 18662
24. H. Walczak, R.E. Miller, K. Ariail, B. Gliniak, T.S. Griffith, M. Kubin, W. Chin, J. Jones, A. Woodward, T. Le, C. Smith, P. Smolak, R.G. Goodwin, C.T. Rauch, J.C. Schuh, and D.H. Lynch Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo Nat. Med. 5 1999 157
25. C. Watzl The NKG2D receptor and its ligands-recognition beyond the "missing self"? Microbes Infect. 5 2003 31
26. C. Watzl, C.C. Stebbins, and E.O. Long NK cell inhibitory receptors prevent tyrosine phosphorylation of the activation receptor 2B4 (CD244) J. Immunol. 165 2000 3545